ARC-100
N/A
Report date: 2024/09/01 20:00:09
NME
Base Information
Drug NameARC-100
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[17]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCortice Biosciences IncTapestry Pharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesUniversity Of California San FranciscoCns Pharmaceuticals IncH Lee Moffitt Cancer Center & Research Institute +[5]
Active IndicationsN/A
Inactive Indications +[17]
Other Information
ATC CodeN/A
Related LinksN/A